Andreas Nechansky
biotechnology
JHL Biotech
Taiwan
Biography
Dr. Andreas Nechansky has more than 15 years of experience in the biotech industry and his last position was Chief Operating Officer of a GMP certified analytical service provider. His experience lies within the field of analytical characterization of Biopharmaceuticals and Biosimilars with a strong focus on Bioassays. Andreas’ vision is to build up a unique team by sharing his expertise and knowledge allowing JHL to deliver world-class Biosimilars to the people in need. Andreas started his career as a postdoctoral fellow at Novartis followed by a position as Research Associate at The Scripps Research Institute. Next he joined the Igeneon/Aphton Biotech company as the Head of Assay Development focusing on developing and clinically profiling monoclonal anti-cancer antibodies. He then co-founded VelaLabs and was responsible for Analytical Operation and Business Development. Andreas has received a Ph.D. degree in Molecular Biology from the University of Vienna, Austria. He has published papers in the area of allergy and oncology and on analytical characterization of antibodies. He is also the inventor of two patents.
Research Interest
..
